Jun 9, 2026 07:30AM
Jun 9, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 2, 2026 07:30AM
Jun 1, 2026 07:30AM
Jun 1, 2026 07:30AM TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology
May 28, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM
May 26, 2026 07:30AM
May 26, 2026 07:30AM
May 6, 2026 07:00AM
May 5, 2026 07:01AM Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
Apr 30, 2026 07:30AM
Apr 22, 2026 07:32AM
Apr 22, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
Mar 12, 2026 07:00AM
Mar 9, 2026 07:31AM
Mar 9, 2026 07:30AM
Mar 6, 2026 07:31AM
Mar 6, 2026 07:30AM
Feb 26, 2026 07:00AM
Feb 23, 2026 07:30AM TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
Feb 17, 2026 07:30AM
Feb 8, 2026 04:17PM
Feb 6, 2026 07:30AM
Feb 6, 2026 07:30AM
Jan 27, 2026 07:32AM
Jan 27, 2026 07:30AM
Jan 13, 2026 04:25PM TG Therapeutics reports $616M 2025 revenue, targets $875-900M for 2026
Jan 13, 2026 04:25PM
Jan 7, 2026 07:30AM
Nov 28, 2025 07:30AM
Nov 19, 2025 08:30AM
Nov 10, 2025 04:00PM
Nov 3, 2025 07:00AM
Oct 31, 2025 07:30AM TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
Oct 28, 2025 07:30AM
Oct 28, 2025 07:30AM
Sep 24, 2025 09:10AM
Sep 24, 2025 09:10AM
Sep 10, 2025 07:30AM
Sep 8, 2025 07:30AM
Sep 8, 2025 07:30AM TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
Sep 4, 2025 07:30AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All